Drugs / Brevail
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 0 | NCT01396369 | Jun 2011 → Dec 2013 | polycystic ovary syndrome | University of Kansas Medical Center | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Brevail | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01396369 ↗ |
| Known as | Flaxseed Lignan | “Flaxseed Lignan (Brevail)” NCT01396369 ↗ |